Sherbrooke Park Advisers LLC Invests $452,000 in Encompass Health Co. (NYSE:EHC)

Sherbrooke Park Advisers LLC bought a new position in shares of Encompass Health Co. (NYSE:EHC - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 4,891 shares of the company's stock, valued at approximately $452,000.

A number of other large investors also recently bought and sold shares of the stock. MassMutual Private Wealth & Trust FSB lifted its position in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after buying an additional 137 shares in the last quarter. Colonial Trust Co SC acquired a new position in Encompass Health during the fourth quarter worth $29,000. Transce3nd LLC acquired a new stake in shares of Encompass Health in the fourth quarter valued at about $40,000. CBIZ Investment Advisory Services LLC grew its position in shares of Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after purchasing an additional 127 shares during the period. Finally, Tompkins Financial Corp purchased a new stake in shares of Encompass Health during the fourth quarter worth about $46,000. 97.25% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Encompass Health

In other news, CEO Mark J. Tarr sold 118,384 shares of the company's stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $121.53, for a total value of $14,387,207.52. Following the transaction, the chief executive officer now owns 527,070 shares of the company's stock, valued at $64,054,817.10. This represents a 18.34% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total value of $498,974.19. Following the transaction, the insider now owns 11,958 shares of the company's stock, valued at approximately $1,394,422.38. This represents a 26.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 132,663 shares of company stock worth $16,034,082 in the last 90 days. Insiders own 2.00% of the company's stock.

Encompass Health Trading Down 0.0%

NYSE EHC traded down $0.00 on Friday, reaching $118.61. 51,007 shares of the company were exchanged, compared to its average volume of 790,941. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. The business's fifty day moving average price is $107.42 and its 200 day moving average price is $101.30. The stock has a market capitalization of $11.96 billion, a P/E ratio of 26.59, a price-to-earnings-growth ratio of 2.31 and a beta of 0.91. Encompass Health Co. has a fifty-two week low of $82.74 and a fifty-two week high of $121.96.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings results on Thursday, April 24th. The company reported $1.37 EPS for the quarter, topping the consensus estimate of $1.19 by $0.18. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. The business had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same quarter in the previous year, the firm earned $1.12 EPS. The company's quarterly revenue was up 10.6% compared to the same quarter last year. Analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be paid a $0.17 dividend. The ex-dividend date is Tuesday, July 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.57%. Encompass Health's dividend payout ratio (DPR) is 14.05%.

Analysts Set New Price Targets

Several equities research analysts have commented on EHC shares. William Blair reiterated an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. Truist Financial reiterated a "buy" rating and set a $135.00 price target (up from $116.00) on shares of Encompass Health in a research report on Monday, April 28th. KeyCorp increased their price objective on Encompass Health from $120.00 to $122.00 and gave the company an "overweight" rating in a research note on Friday, April 25th. UBS Group lifted their target price on shares of Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research note on Monday, April 28th. Finally, Wall Street Zen raised shares of Encompass Health from a "hold" rating to a "buy" rating in a report on Sunday, May 11th. Nine investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Buy" and a consensus price target of $120.86.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.